Colorectal Liver Metastases: Is ‘No Treatment’ Still Best?

Office of Population, Censuses, and Surveys. Cancer Registry, Welsh Office: HMSO, 1980

Viadana E Bross IDJ Pickren JW . The metastatic spread of cancers of the digestive system in man. Oncology 1978; 35: 114–26

Welch JP Donaldson GA . The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189: 496–502

Daly JM Butler J Kemeny N Yeh SJ Ridge JA Botet J Bading JR DeCosse JJ Benua RS . Predicting tumour response in patients with colorectal hepatic metastases. Cancer 1985; 202: 384–93

Bross ID Blumenson LE . Metastatic sites that produce generalized cancer: Identification and kinetics of generalizing sites. In: Weiss L ed. Fundamental aspects of metastasis. Amsterdam: North Holland, 1976: 359–75.

Jaffe BM Donegan WR Watson F Spratt JS . Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127: 1–11

Wagner JS Adson MA Van Heerden JA Adson MH Ilstrup DM . The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984; 199: 502–8

Fortner JG Silva JS Golbey RB Cox EB Maclean BJ . Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. 1: Treatment by hepatic resection. Ann Surg 1983; 199: 306–16

August DA Ottow RT Sugarbaker PH . Clinical perspective of human colorectal cancer metastasis. Canc Met Rev 1984; 3: 303–24

Department of Health and Social Security, Form SH3 regional and national summaries for 1980. London DHSS, 1981

Carter SK . Large bowel cancer: The current status of treatment. J Nat Canc Inst 1976; 56: 3–10

Kemeny N Yagoda A Braun D. Metastatic colorectal carcinoma. A prospective randomised trial of methyl CCNU, 5-fluorouracil (5FU) and vincristine (MOF) vs MOF plus streptozatocin(MOF strep). Cancer 1983; 5120–4

Kemeny N Daly J Reichman B Geller N Botet J Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987; 107: 459–65

Allen-Mersh TG Kemeny N Niedzwiecki D Shurgot B Daly JM . Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer. Gut 1987; 28: 1625–9

Ensminger WD Rosowski A Raso V . A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 1978; 38: 3784–92.

Frei E. Effect of dose and schedule on response. In: Holland JF Frei E , eds. Cancer medicine. Philadelphia: Lea & Febiger, 1973: 717–30

Ensminger WD Gyves JW . Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983; 10: 176–82

Taylor I Machin D Mullee M Trotter G Cooke T West C. A randomised controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. B J Surg 1985; 72: 359–63

Ansfield FJ Ramirez G Davis HL Wirtanen GW Johnson RO Bryan GT Manalo FB Borden EC Davis TE Esmaili M. Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer 1975; 36: 2413–7

Cady B Oberfield RA . Regional infusion chemotherapy Of hepatic metastases from carcinoma of the colon. Am J Surg 1974; 127: 220–7

Cady B. Hepatic arterial patency and complications after catheterisation and infusion chemotherapy. Ann Surg 1973; 178: 156–61

Balch CM Urist MM Seng-Jaw S McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983; 198: 567–73

Cohen AM Kaufman SD Wood WC . Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy. Dis Colon Rectum 1985; 28: 389–93

Niederhuber J Ensmingr W Gyves J Thrall J Walker S Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984; 53: 1336–43

Balch CM Urist MM McGregor ML . Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg 1983; 14: 285–90

Hohn DC Rayner AA Economou J Ignoffo RJ Lewis BJ Stagg RJ . Toxicities and complications of implanted pump hepatic arterial and intravenous infusion. Cancer 1986; 57: 465–9

Stoll BA . Balancing cost and benefit in treatment of late cancer. Lancet 1988; i: 579–80